dasatinib pharmadvice 50 mg film-coated tablets
50 mg film-coated tablets
dasatinib pharmadvice 70 mg film-coated tablets
70 mg film-coated tablets
dasatinib pharmadvice 80 mg film-coated tablets
80 mg film-coated tablets
dasatinib pharmadvice 100 mg film-coated tablets
100 mg film-coated tablets
dasatinib pharmadvice 140 mg film-coated tablets
140 mg film-coated tablets
iclusig
incyte biosciences distribution b.v. - ponatinib - leukemia, myeloid; leukemia, lymphoid - antineoplastic agents, protein kinase inhibitors - iclusig is indicated in adult patients withchronic phase, accelerated phase, or blast phase chronic myeloid leukaemia (cml) who are resistant to dasatinib or nilotinib; who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutationphiladelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) who are resistant to dasatinib; who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate; or who have the t315i mutation. Вижте раздели 4. 2 assessment of cardiovascular status prior to start of therapy and 4. 4 situations where an alternative treatment may be considered.
neumutil 10% premix 100 g
Фарма СИС БГ ООД - Тиамулина гидроген фумарат - медикаментозен премикс - 100 g - пилета, прасета
neumutil 10% premix 100 g
Фарма СИС ООД - Тиамулина гидроген фумарат - медикаментозен премикс - 100 g - пилета, прасета